Inventor · disambiguated record
Camellia W. Adams
Also filed as: ADAMS CAMELLIA W
25 granted patents·11 pending applications·1,890 citations·filing 1997–2021
97Inventor score
Top patents by PatentIndex Score
36 records- 0199US7862817B2Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2005·Granted Jan 4, 2011·126 cites·23 claims
- 0299US7537931B2Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodiesGENENTECH INC·Filed 2006·Granted May 26, 2009·83 cites·24 claims
- 0399US7501122B2Treatment with anti-ErbB2 antibody combinationsGENENTECH INC·Filed 2005·Granted Mar 10, 2009·76 cites·9 claims
- 0499US7498030B2Treatment with anti-ErbB2 antibodies and anti-hormonal compoundsGENENTECH INC·Filed 2005·Granted Mar 3, 2009·69 cites·14 claims
- 0599US7485302B2Treatment with anti-ErbB2 antibodies and chemotherapeutic agentsGENENTECH INC·Filed 2006·Granted Feb 3, 2009·109 cites·30 claims
- 0698US8030023B2Nucleic acid encoding DR5 antibodies and uses thereofGENENTECH INC·Filed 2006·Granted Oct 4, 2011·56 cites·8 claims
- 0798US7799900B2Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Granted Sep 21, 2010·103 cites·19 claims
- 0897US8562992B2Immunoglobulin variants and uses thereofADAMS CAMELLIA W·Filed 2008·Granted Oct 22, 2013·69 cites·6 claims
- 0997US7527791B2Humanized anti-TGF-beta antibodiesGENENTECH INC·Filed 2005·Granted May 5, 2009·1k cites·26 claims
- 1094US8029783B2DR5 antibodies and articles of manufacture containing sameGENENTECH INC·Filed 2006·Granted Oct 4, 2011·22 cites·42 claims
- 1193US7314619B2Inducing apoptosis using anti-Apo-2 antibodiesGENENTECH INC·Filed 2001·Granted Jan 1, 2008·18 cites·33 claims
- 1292US6342220B1Agonist antibodiesGENENTECH INC·Filed 1997·Granted Jan 29, 2002·90 cites·14 claims
- 1391US7595046B2Treatment of cancer using anti-Apo-2 antibodiesGENENTECH INC·Filed 2005·Granted Sep 29, 2009·4 cites·25 claims
- 1488US8012482B2Humanized anti-TGF-beta antibodiesGENENTECH INC·Filed 2009·Granted Sep 6, 2011·11 cites·26 claims
- 1586US8409570B2Method of inducing apoptosis using anti-DR5 antibodiesADAMS CAMELLIA W·Filed 2011·Granted Apr 2, 2013·4 cites·16 claims
- 1684US7807153B2Apo-2 receptor agonist antibodiesGENENTECH INC·Filed 2003·Granted Oct 5, 2010·4 cites·52 claims
- 1783US8092799B2Antibodies to Apo-2 receptor polypeptidesADAMS CAMELLIA W·Filed 2010·Granted Jan 10, 2012·2 cites·22 claims
- 1883US7923011B2Antibodies to lymphotoxin-alphaGENENTECH INC·Filed 2007·Granted Apr 12, 2011·4 cites·21 claims
- 1977US7354585B2Methods of treating coagulapathic or thrombotic disordersGENENTECH INC·Filed 2006·Granted Apr 8, 2008·2 cites·15 claims
- 2076US2022002430A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2170US6737249B1Agonist antibodiesGENENTECH INC·Filed 1998·Granted May 18, 2004·16 cites·12 claims
- 2265US2019071511A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2364US2011129464A1Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodiesGENENTECH INC·Filed 2010·Application pending·0 cites
- 2463US2005208585A1Agonist antibodiesADAMS CAMELLIA W·Filed 2004·Application pending·0 cites
- 2563US2014154242A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 2662US6624295B1Human anti-factor IX/IXa antibodiesGENENTECH INC·Filed 1999·Granted Sep 23, 2003·14 cites·8 claims
- 2761US2017158773A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 2859US8642740B2Antibodies to lymphotoxin-alphaADAMS CAMELLIA W·Filed 2012·Granted Feb 4, 2014·0 cites·12 claims
- 2959US2006024300A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 3057US8216807B2Antibodies to lymphotoxin-αADAMS CAMELLIA W·Filed 2011·Granted Jul 10, 2012·0 cites·13 claims
- 3157US2003148455A1Apo-2 receptorGENENTECH INC·Filed 2002·Application pending·0 cites
- 3257US2006177441A1Agonist antibodiesADAMS CAMELLIA W·Filed 2006·Application pending·0 cites
- 3356US8541552B2Antibodies to lymphotoxin-αADAMS CAMELLIA W·Filed 2011·Granted Sep 24, 2013·0 cites·64 claims
- 3455US7049411B2Human anti-factor IX/IXa antibodiesGENENTECH INC·Filed 2003·Granted May 23, 2006·0 cites·20 claims
- 3544US2006246004A1Antibody variants and uses thereofGENENTECH INC·Filed 2006·Application pending·0 cites
- 3640US2006067930A1Polypeptide variants with altered effector functionGENENTECH INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Camellia W. Adams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →